DK1729796T3 - Behandling af tryksår - Google Patents

Behandling af tryksår

Info

Publication number
DK1729796T3
DK1729796T3 DK05731043T DK05731043T DK1729796T3 DK 1729796 T3 DK1729796 T3 DK 1729796T3 DK 05731043 T DK05731043 T DK 05731043T DK 05731043 T DK05731043 T DK 05731043T DK 1729796 T3 DK1729796 T3 DK 1729796T3
Authority
DK
Denmark
Prior art keywords
treatment
pressure ulcers
pressure
pressure sore
sore
Prior art date
Application number
DK05731043T
Other languages
English (en)
Inventor
Eric R First
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1729796T3 publication Critical patent/DK1729796T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Processing Of Meat And Fish (AREA)
DK05731043T 2004-03-31 2005-03-28 Behandling af tryksår DK1729796T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/814,764 US20050220821A1 (en) 2004-03-31 2004-03-31 Pressure sore treatment
PCT/US2005/010461 WO2005097178A1 (en) 2004-03-31 2005-03-28 Pressure sore treatment

Publications (1)

Publication Number Publication Date
DK1729796T3 true DK1729796T3 (da) 2009-01-19

Family

ID=34964467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05731043T DK1729796T3 (da) 2004-03-31 2005-03-28 Behandling af tryksår

Country Status (10)

Country Link
US (2) US20050220821A1 (da)
EP (1) EP1729796B1 (da)
JP (2) JP2007531747A (da)
AT (1) ATE412424T1 (da)
AU (1) AU2005231360B2 (da)
BR (1) BRPI0509478A (da)
CA (1) CA2561588C (da)
DE (1) DE602005010676D1 (da)
DK (1) DK1729796T3 (da)
WO (1) WO2005097178A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
US20070238630A1 (en) * 2006-03-29 2007-10-11 Phillips Douglas H Subcutaneous skin cleanser
EP2841095A4 (en) * 2012-03-22 2016-01-13 Revance Therapeutics Inc PROCESS FOR TREATING WRINKLES IMPRINATING TOPICAL CHEMODENERVATION AGENTS

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330527A (en) * 1979-11-13 1982-05-18 Teruo Arima Wound treatment agent
US4805605A (en) * 1988-01-11 1989-02-21 Glassman Medical Products, Inc. Abduction pillow
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5562907A (en) * 1993-05-14 1996-10-08 Arnon; Stephen S. Method to prevent side-effects and insensitivity to the therapeutic uses of toxins
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
JPH07118165A (ja) * 1993-10-22 1995-05-09 Asahi Chem Ind Co Ltd カルシトニン遺伝子関連ペプチド類を含有する経皮吸収組成物
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) * 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) * 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
DK1086702T3 (da) * 1994-05-09 2005-05-23 William J Binder Præsynaptiske neurotoksiner til behandling af migrænehovedpine
JPH0840926A (ja) * 1994-08-03 1996-02-13 Yakurigaku Chuo Kenkyusho:Kk 皮膚潰瘍治療薬
GB9508204D0 (en) * 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
ES2198484T3 (es) * 1995-06-06 2004-02-01 L. Bruce Pearce Composiciones y procedimientos mejorados para quimiodenervacion usando neurotoxinas.
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
US6670337B1 (en) * 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6503539B2 (en) * 1998-02-27 2003-01-07 Biora Bioex Ab Matrix protein compositions for wound healing
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
CA2347828A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
US6139845A (en) * 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6429189B1 (en) * 1999-12-10 2002-08-06 Botulinum Toxin Research Associates, Inc. Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
US6143306A (en) * 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) * 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US20020192798A1 (en) * 2000-08-07 2002-12-19 Holloway James L. Zcys9: a member of the cystatin superfamily
JP4096115B2 (ja) * 2000-08-10 2008-06-04 輝夫 西田 皮膚創傷治癒促進剤
US6678651B2 (en) * 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
WO2002046412A2 (en) * 2000-12-07 2002-06-13 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US20020192239A1 (en) * 2001-01-09 2002-12-19 Borodic Gary E. Use of botulinum toxin for the treatment of chronic facial pain
US7108683B2 (en) * 2001-04-30 2006-09-19 Kci Licensing, Inc Wound therapy and tissue management system and method with fluid differentiation
DK1411978T3 (da) 2001-07-27 2009-01-05 Univ Louisiana State Botulinum-toksin ved behandlingen eller forebyggelsen af acne
US7597911B2 (en) * 2001-08-16 2009-10-06 Curapharm, Inc. Method and composition for treatment of wounds and burns
AU2003212473A1 (en) * 2002-03-01 2003-09-16 Solstice Neurosciences, Inc. Methods of treating nerve entrapment syndromes
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
RS52750B (sr) * 2002-08-12 2013-08-30 Birkir Sveinsson Upotreba cgrp antagonista za lečenje psorijaze
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
WO2004033668A2 (en) * 2002-10-10 2004-04-22 Diversa Corporation Proteases, nucleic acids encoding them and methods for making and using them
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
JP2007526316A (ja) * 2004-03-01 2007-09-13 ルーメン セラピューティックス リミテッド ライアビリティ カンパニー 疾患を処置するための組成物および方法
JP5095388B2 (ja) * 2004-03-03 2012-12-12 ルバンス セラピュティックス インク． ボツリヌストキシンの局所適用及び経皮送達のための組成物及び方法
CN1997373B (zh) * 2004-05-07 2010-12-22 菲特托克斯有限公司 藻毒素及其用途
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US20060067950A1 (en) * 2004-09-27 2006-03-30 Merz Pharma Gmbh & Co. Kgaa Clostridial neurotoxins for use in wound healing
EP1986731A4 (en) * 2006-02-09 2012-11-07 Aderans Res Inst Inc APPARATUS AND METHODS FOR DELIVERING FLUID AND MATERIAL TO A SUBJECT
US9283217B2 (en) * 2011-11-10 2016-03-15 Allergan, Inc. Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Also Published As

Publication number Publication date
US20050220821A1 (en) 2005-10-06
US20080050404A1 (en) 2008-02-28
AU2005231360B2 (en) 2009-10-29
WO2005097178A1 (en) 2005-10-20
JP2007531747A (ja) 2007-11-08
US8865177B2 (en) 2014-10-21
EP1729796A1 (en) 2006-12-13
CA2561588C (en) 2012-08-28
BRPI0509478A (pt) 2007-09-11
JP2013075902A (ja) 2013-04-25
AU2005231360A1 (en) 2005-10-20
ATE412424T1 (de) 2008-11-15
EP1729796B1 (en) 2008-10-29
JP5674164B2 (ja) 2015-02-25
DE602005010676D1 (de) 2008-12-11
CA2561588A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
ATE462443T1 (de) Dehnungsstreifenbehandlung mit botulinumtoxin
DK2154151T3 (da) Clostridiumtoksinaktiverbare clostridiumtoksiner
ATE424159T1 (de) Katheter
TW200503751A (en) Methods for treating sinus headache
BR0307496A (pt) Uso de uma neurotoxina clostridiana, bem como composição farmacêutica utilizável no tratamento de um distúrbio da glândula mamária
DK1322324T3 (da) Fremgangsmåder til behandling af muskelskader
DK2282766T3 (da) Suturlinie-indgivelsesteknik med anvendelse af botulinumtoksiner
ATE416191T1 (de) Abbaubare clostridientoxine
DK1802274T3 (da) Anvendelse af cannabidiol i inhibitionen af hjernetumorcellemigration
DK1558279T3 (da) Botulinumtoksin til behandling af ulcus pepticum og gastroesophageal reflux-sygdom
DE60111570D1 (de) Isoindolin-1-on als glukokinaseaktivatoren
WO2008051197A3 (en) Small-molecule botulinum toxin inhibitors
ATE347898T1 (de) Botulinustoxine zur behandlung von priapismus
WO2010014854A3 (en) Antibodies that neutralize botulinum neurotoxins
ATE491374T1 (de) Eckstück für eine matratze sowie matratze und entsprechendes herstellungsverfahren
DE602005021619D1 (de) Mikrobielle vitamin-c-produktion
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
EA200800889A1 (ru) Гексагидроциклооктилпиразольные каннабиноидные модуляторы
CY1114792T1 (el) Κλωστριδιακες τοξινες για χρηση στην θεραπεια προωρης εκσπερματισης
EA201070074A1 (ru) Разлагаемые гели для применения для разобщения зон
DE602007002625D1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
DK1729796T3 (da) Behandling af tryksår
WO2009130600A3 (en) Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
BRPI0514836A (pt) uso de toxina botulìnica para tratamento de uma deformidade da nádega
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран